![Mark Krembil](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Krembil
Vorsitzender bei panCELLa, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michael Tymianski | M | - |
NoNO, Inc.
![]() NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | 21 Jahre |
Kunal Gupta | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | 17 Jahre |
Rahul Agarwal | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | 17 Jahre |
Michael W. Salter | M | - |
NoNO, Inc.
![]() NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | 21 Jahre |
Pratik Rathod | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | 17 Jahre |
Armand Keating | M | - |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | 9 Jahre |
Andras Nagy | M | - |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | 9 Jahre |
Wayne Marshall | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Michael Russo | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | 17 Jahre |
Andreas Scheel | M | - |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | - |
Brian Levitt | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Glenys Foster-Roberts | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Nizar Mahomed | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Josh Josephson | M | - |
NoNO, Inc.
![]() NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | - |
Greg Wolfond | M | - |
NoNO, Inc.
![]() NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | - |
Steve Irvine | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | - |
Martin Goldfarb | M | - |
NoNO, Inc.
![]() NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | - |
Thomas Jenen | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | 9 Jahre |
James M. Lamberti | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | - |
John Francis | M | - |
NoNO, Inc.
![]() NoNO, Inc. Pharmaceuticals: MajorHealth Technology NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada. | - |
Mahendra S. Rao | M | 61 |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | - |
Brooke Ablon | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | 2 Jahre |
Andrew Shannon | M | - |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | - |
Justin LaFayette | M | 52 |
Nova, Inc. (Canada)
![]() Nova, Inc. (Canada) Information Technology ServicesTechnology Services Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada. | - |
Jason Carstens | M | - |
panCELLa, Inc.
![]() panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Kanada | 25 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mark Krembil
- Persönliches Netzwerk